As of Feb 27
| -0.10 / -1.12%|
The 4 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +46.73% increase from the last price of 8.86.
The current consensus among 5 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.